1. Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research
Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive
Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice
of Customer
5.
Global Stomach Cancer Treatment
Market Outlook
5.1. Market
Size & Forecast
5.1.1. By
Value
5.2. Market
Share & Forecast
5.2.1.
By Treatment Type (Immunotherapy, Targeted
Therapy, Chemotherapy, Radiation Therapy, Others)
5.2.2.
By Cancer Type (Gastric
Cancer/Gastroesophageal Junction Cancer v/s Gastrointestinal Stromal Tumors)
5.2.3.
By Route of Administration (Oral v/s
Injectables)
5.2.4.
By Drug Class (PD-1/PD-L1 Inhibitors, HER2
Antagonists, VEGFR2 Antagonists, Others)
5.2.5.
By Distribution Channel (Hospital Pharmacies,
Specialty Pharmacies, Others)
5.2.6.
By Region
5.2.7. By
Company (2022)
5.3. Market
Map
5.3.1. By
Treatment Type
5.3.2. By
Cancer Type
5.3.3. By
Route of Administration
5.3.4. By
Drug Class
5.3.5. By
Distribution Channel
5.3.6. By
Region
6.
North America Stomach Cancer Treatment
Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1.
By Treatment Type
6.2.2.
By Cancer Type
6.2.3.
By Route of Administration
6.2.4.
By Drug Class
6.2.5.
By Distribution Channel
6.2.6. By Country
6.3. North
America: Country Analysis
6.3.1. United
States Stomach Cancer Treatment Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Treatment Type
6.3.1.2.2.
By Cancer Type
6.3.1.2.3.
By Route of Administration
6.3.1.2.4.
By Drug Class
6.3.1.2.5.
By Distribution Channel
6.3.2. Canada
Stomach Cancer Treatment Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Treatment Type
6.3.2.2.2.
By Cancer Type
6.3.2.2.3.
By Route of Administration
6.3.2.2.4.
By Drug Class
6.3.2.2.5.
By Distribution Channel
6.3.3. Mexico
Stomach Cancer Treatment Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Treatment Type
6.3.3.2.2.
By Cancer Type
6.3.3.2.3.
By Route of Administration
6.3.3.2.4.
By Drug Class
6.3.3.2.5.
By Distribution Channel
7.
Europe Stomach Cancer Treatment
Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1.
By Treatment Type
7.2.2.
By Cancer Type
7.2.3.
By Route of Administration
7.2.4.
By Drug Class
7.2.5.
By Distribution Channel
7.2.6.
By Country
7.3. Europe:
Country Analysis
7.3.1. France
Stomach Cancer Treatment Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Treatment Type
7.3.1.2.2.
By Cancer Type
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By Drug Class
7.3.1.2.5.
By Distribution Channel
7.3.2. Germany
Stomach Cancer Treatment Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Treatment Type
7.3.2.2.2.
By Cancer Type
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By Drug Class
7.3.2.2.5.
By Distribution Channel
7.3.3. United
Kingdom Stomach Cancer Treatment Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Treatment Type
7.3.3.2.2.
By Cancer Type
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By Drug Class
7.3.3.2.5.
By Distribution Channel
7.3.4. Italy
Stomach Cancer Treatment Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Treatment Type
7.3.4.2.2.
By Cancer Type
7.3.4.2.3.
By Route of Administration
7.3.4.2.4.
By Drug Class
7.3.4.2.5.
By Distribution Channel
7.3.5. Spain
Stomach Cancer Treatment Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Treatment Type
7.3.5.2.2.
By Cancer Type
7.3.5.2.3.
By Route of Administration
7.3.5.2.4.
By Drug Class
7.3.5.2.5.
By Distribution Channel
8.
Asia-Pacific Stomach Cancer Treatment
Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1.
By Treatment Type
8.2.2.
By Cancer Type
8.2.3.
By Route of Administration
8.2.4.
By Drug Class
8.2.5.
By Distribution Channel
8.2.6. By
Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China
Stomach Cancer Treatment Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Treatment Type
8.3.1.2.2.
By Cancer Type
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By Drug Class
8.3.1.2.5.
By Distribution Channel
8.3.2. India
Stomach Cancer Treatment Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Treatment Type
8.3.2.2.2.
By Cancer Type
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By Drug Class
8.3.2.2.5.
By Distribution Channel
8.3.3. Japan
Stomach Cancer Treatment Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Treatment Type
8.3.3.2.2.
By Cancer Type
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By Drug Class
8.3.3.2.5.
By Distribution Channel
8.3.4. South
Korea Stomach Cancer Treatment Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Treatment Type
8.3.4.2.2.
By Cancer Type
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By Drug Class
8.3.4.2.5.
By Distribution Channel
8.3.5. Australia
Stomach Cancer Treatment Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Treatment Type
8.3.5.2.2.
By Cancer Type
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By Drug Class
8.3.5.2.5.
By Distribution Channel
9.
South America Stomach Cancer Treatment
Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1.
By Treatment Type
9.2.2.
By Cancer Type
9.2.3.
By Route of Administration
9.2.4.
By Drug Class
9.2.5.
By Distribution Channel
9.2.6. By
Country
9.3. South
America: Country Analysis
9.3.1. Brazil
Stomach Cancer Treatment Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Treatment Type
9.3.1.2.2.
By Cancer Type
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By Drug Class
9.3.1.2.5.
By Distribution Channel
9.3.2. Argentina
Stomach Cancer Treatment Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Treatment Type
9.3.2.2.2.
By Cancer Type
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By Drug Class
9.3.2.2.5.
By Distribution Channel
9.3.3. Colombia
Stomach Cancer Treatment Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Treatment Type
9.3.3.2.2.
By Cancer Type
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By Drug Class
9.3.3.2.5.
By Distribution Channel
10. Middle
East and Africa Stomach Cancer Treatment Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1.
By Treatment Type
10.2.2.
By Cancer Type
10.2.3.
By Route of Administration
10.2.4.
By Drug Class
10.2.5.
By Distribution Channel
10.2.6. By
Country
10.3.
MEA: Country Analysis
10.3.1. South
Africa Stomach Cancer Treatment Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Treatment Type
10.3.1.2.2.
By Cancer Type
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By Drug Class
10.3.1.2.5.
By Distribution Channel
10.3.2. Saudi
Arabia Stomach Cancer Treatment Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Treatment Type
10.3.2.2.2.
By Cancer Type
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By Drug Class
10.3.2.2.5.
By Distribution Channel
10.3.3. UAE
Stomach Cancer Treatment Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Treatment Type
10.3.3.2.2.
By Cancer Type
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By Drug Class
10.3.3.2.5.
By Distribution Channel
10.3.4. Turkey
Stomach Cancer Treatment Market Outlook
10.3.4.1. Market
Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market
Share & Forecast
10.3.4.2.1.
By Treatment Type
10.3.4.2.2.
By Cancer Type
10.3.4.2.3.
By Route of Administration
10.3.4.2.4.
By Drug Class
10.3.4.2.5.
By Distribution Channel
10.3.5. Egypt
Stomach Cancer Treatment Market Outlook
10.3.5.1. Market
Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market
Share & Forecast
10.3.5.2.1.
By Treatment Type
10.3.5.2.2.
By Cancer Type
10.3.5.2.3.
By Route of Administration
10.3.5.2.4.
By Drug Class
10.3.5.2.5.
By Distribution Channel
11. Market
Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market
Trends & Developments
12.1.
Recent Developments
12.2.
Mergers & Acquisitions
12.3.
Product Launches
13. Competitive
Landscape
13.1.
Business Overview
13.2.
Product Offerings
13.3.
Recent Developments
13.4.
Financials (As Reported)
13.5.
Key Personnel
13.6.
SWOT Analysis
13.6.1. Pfizer,
Inc.
13.6.2. Novartis
International AG
13.6.3. Eli
Lilly and Company
13.6.4. Bristol
Myers Squibb Company
13.6.5. Teva
Pharmaceutical Industries AG
13.6.6. F.
Hoffmann La Roche AG
13.6.7. Mylan
N.V.
13.6.8. Celltrion
Healthcare Co., Ltd
13.6.9. Merck
& Co., Inc.
13.6.10.
Teva Pharmaceutical Industries Ltd.
Strategic
Recommendations